OMRON Strengthens Engagement with AliveCor with Series E Inves... - 24 November 2020 18:00

KYOTO, Nov. 24, 2020 /Kyodo JBN-AsiaNet/ -- OMRON Healthcare Co., Ltd. announced on November 24 additional investment into AliveCor by its parent company, OMRON Corporation, as part of $65 million series E funding for the leader in AI-based personal electrocardiogram (ECG) technology. OMRON...

  Thermo Scientific Axia ChemiSEM Increases Data Acquisition Spe... - 24 November 2020 10:00

HILLSBORO, Oregon, Nov. 24, 2020 /PRNewswire-AsiaNet/ -- -- New all-in-one SEM-EDS platform provides high-quality quantitative elemental data twice as fast as competing solutions Thermo Fisher Scientific today unveiled the Thermo Scientific Axia ChemiSEM, a cost-effective, floor-model scanning electr...

  Koru Lifescience preparing to send drug compounds to preclinic... - 24 November 2020 07:45

AUCKLAND, New Zealand, Nov. 24, 2020 /PRNewswire-AsiaNet/ -- Koru Lifescience, drug discovery, and advanced formulation research laboratory in Auckland, New Zealand, has identified several known drug compounds of value in their study for a treatment of Covid-19. The study reports shall be published after a ...

  Texas Cardiac Arrhythmia Institute at St. David's Medical Cent... - 24 November 2020 05:49

AUSTIN, Texas, Nov. 24, 2020 /PRNewswire-AsiaNet/ -- -- EPLive 2020, a two-day educational conference, uses live cases as primary teaching tool On December 3 and 4, 2020, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center will host its fifth international symposium on co...

  GemVax & KAEL Reports Further Positive Data from GV1001 Phase ... - 23 November 2020 23:00

SEOUL, Nov. 20, 2020, /PRNewswire-AsiaNet/-- GemVax & KAEL Co., Ltd. a clinical stage company developing a novel peptide drug based on telomerase modification has released further positive data at the Korean Dementia Association's Fall Conference from a Phase II trial in Alzheimer's disease ...

  Fresenius Kabi and ASPEN Partner for an Expert Interview Serie... - 23 November 2020 22:00

BAD HOMBURG, Germany, Nov. 23, 2020, /PRNewswire-AsiaNet/-- Evidence indicates that omega-3 (w-3) fatty acid containing parenteral nutrition (PN) improves clinical outcomes compared with standard PN in adult patients,1 underlining its role in today's hospitals and clinics. To support continuous health care...

  Cipla launches 'Covi-G' for COVID-19 rapid antibody detection - 23 November 2020 17:38

MUMBAI, Nov. 23, 2020 /PRNewswire-AsiaNet/ -- Cipla signed a licensing agreement with MultiG for COVID-19 rapid antibody test kit Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) and hereafter referred to as "Cipla") today announced that it signed a licensing agreement with a Belgium-...

  Creation of a research partnership between Pierre Fabre and Y-... - 23 November 2020 09:00

DAEJEON, South Korea and CASTRES, France, Nov. 23, 2020 /PRNewswire-AsiaNet/-- The South Korean biotech company Y-Biologics and the French pharmaceutical group Pierre Fabre have announced their plans to form a strategic partnership in the field of immuno-oncology research. The decision has been acknowledged through a letter ...

  RedHill Biopharma Initiates Phase 3 Study of RHB-204 for First... - 21 November 2020 00:20

TEL AVIV, Israel and RALEIGH, N.C., November 20, 2020, /PRNewswire-AsiaNet/-- RHB-204 is being evaluated as a first-line, stand-alone, oral treatment for pulmonary nontuberculous mycobacteria (NTM) disease - a rare condition with no FDA-approved first-line therapy The Phase 3 study is expected to recruit up to 125 patien...

  INOVIO Presents Clinical Results of its DNA Medicines INO-5401... - 21 November 2020 00:00

PLYMOUTH MEETING, Pennsylvania Nov. 20, 2020 /PRNewswire-AsiaNet/ -- -- Interim review in newly diagnosed glioblastoma patients provides OS18 data, demonstrates immunogenicity and tolerability in a majority of patients INOVIO (NASDAQ: INO), a biotechnology company focused on rapidly bringing to market precisely...